VEGFA and age-related macular degeneration: We conducted the ANGEL (ANalysis of GEnotypes associated with the treatment effects of Lucentis for age-related macular degeneration) study in Japan to perform a GWAS on the outcome of anti-VEGF treatment in a prospective cohort.